Binding Buffer A (ready to use)

Hazard statements (CLP)

H225, H319, H336

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

Highly flammable liquid and vapour. May cause drowsiness or dizziness. Causes serious eye irritation.

2.2 Label elements

Labelling

Hazard pictograms

GHS02 GHS07

Signal word

Danger

Contains

propan-2-ol; isopropyl alcohol; isopropanol

Hazard statements

H225 - Highly flammable liquid and vapour. H319 - Causes serious eye irritation. H336 - May cause drowsiness or dizziness.

Precautionary statements

P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 - Keep container tightly closed. P240 - Ground and bond container and receiving equipment. P241 - Use explosion-proof electrical/ventilating/lighting equipment. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P303+P361+P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water . P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call a POISON CENTRE or doctor if you feel unwell. P337+P313 - If eye irritation persists: Get medical advice/attention. P370+P378 - In case of fire: Use media other than water to extinguish. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %